Morphic Holding Inc Annual Shareholders Meeting Transcript
Thank you all. At this time, I would like to hand the call over to Dr. Praveen Tipirneni, President, Chief Executive Officer, and Director of Morphic Holding and Chair of this meeting.
Dr. Tipirneni, please go ahead.
Thank you, operator. Good morning, ladies and gentlemen. I am Praveen Tipirneni, President, CEO and Director of Morphic Holding. It is my pleasure on behalf of our team, the founders of Morphic, and our Board of Directors to welcome you to the Annual Meeting of Morphic Stockholders. Thank you for joining us today in this Virtual Meeting of stockholders.
2022 was a year of excellent execution at Morphic, leading to the recent announcement of the successful EMERALD-1 study by our lead candidate, MORF-057 in inflammatory bowel disease. I would like to thank all of our shareholders for their support throughout 2022 and into the current year. Your backing has contributed to our efforts and success thus far. We aim to continue this track record going forward.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
